This process enables preparation of the preferred (+)-threo enantiomer by resolution of its racemic mixture of a compound of the formula
wherein Y1 and Y2 are each independently lower alkyl and R1 is hydrogen or lower alkyl. The compound is treated with a chiral acid (tartaric acid preferred) in an organic solvent (ethanol preferred) to yield the (+)-threo enantiomer, which is then recovered from the reaction mixture. This enantiomer may then be used to produce the preferred (+)-cis enantiomer of certain benzothiazepine cardiovascular agents.
该工艺可通过解析式中化合物的外消旋混合物,制备优选的(+)-三对映体。
其中 Y1 和 Y2 各自独立地为低级烷基,R1 为氢或低级烷基。在有机溶剂(
乙醇为佳)中用手性酸(
酒石酸为佳)处理该化合物,生成(+)-三对映体,然后从反应混合物中回收该对映体。这种对映体可用于生产某些苯并
硫氮杂卓类心血管药物的(+)-顺式对映体。